Tag Archives: KOS

Analysts’ Perspective: Dicerna Pharmaceuticals (DRNA), Kosmos Energy (KOS), Square (SQ)

Investment Analysts at B. Riley FBR upgrade Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) shares from Neutral to Buy rating while increasing their price target from $13.50 to $21.

Dicerna Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery and development of pharmaceuticals for the treatment of rare, viral infectious, chronic liver, and cardiovascular diseases.

*

Brokerage Firm Goldman upgraded Kosmos Energy Ltd (NYSE:KOS) shares from Neutral to Buy rating.

Kosmos Energy Ltd. explores for and produces oil and gas in Africa and South America.

*

Square, Inc. (NYSE:SQ) shares were upgraded by analysts at Citigroup from Neutral to Buy rating.

Square, Inc. provides payment and point-of-sale solutions in the United States and internationally.

**

Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. CRWE.Info is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at http://www.crwe.info/disclaimer/

Analysts’ Perspective: Western Gas Partners (WES), Kosmos Energy (KOS), Buffalo Wild Wings (BWLD)

Western Gas Partners LP (NYSE:WES) shares were upgraded by analysts at Stifel from Hold to Buy rating with a price target of $54.

Western Gas Partners LP engages in owning, operating, acquiring, and developing of midstream energy assets.

*

Brokerage Firm Scotia Howard Weil upgraded Kosmos Energy Ltd. (NYSE:KOS) shares from Sector Perform to Sector Outperform rating.

Kosmos Energy Ltd. is an independent oil and gas exploration and production company, which focuses on frontier and emerging areas in Africa and South America.

*

Investment Analysts at Dougherty & Company upgraded Buffalo Wild Wings Inc. (NASDAQ:BWLD) shares from Neutral to Buy rating with a price target of $150.

Buffalo Wild Wings, Inc. owns, operates and franchises restaurants.

**

Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. CRWE.Info is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at http://www.crwe.info/disclaimer/